Massachusetts Sues Drug Executives Over Opioid Crisis
The suit, the first to target company executives, alleges that Purdue Pharma misled doctors and patients about risks and "peddled falsehoods" to sell more drugs and boost profits.BOSTON—Massachusetts is suing the maker of OxyContin over the deadly opioid crisis and is the first state to also target company executives.
Attorney General Maura Healey on Tuesday announced the lawsuit against Purdue Pharma and 16 current and former executives and board members, including CEO Craig Landau and members of the Sackler family, which owns the company.
The suit alleges Purdue misled doctors and patients about the risks of opioids and “peddled falsehoods” to sell more drugs and boost profits.
Healey says the Connecticut-based company’s “illegal business model” has left a “path of devastation and destruction.”
Several other states and localities have sued Purdue Pharma, but Healey says the Massachusetts lawsuit is the first to also name its executives.
Purdue Pharma told the Boston Globe it “vigorously” denies the allegations.
TRUTHDIG’S JOURNALISM REMAINS CLEARThe storytellers of chaos tried to manipulate the political and media narrative in 2025, but independent journalism exposed what they tried to hide. When you read Truthdig, you see through the illusion.
Support Independent Journalism.
Immigration
Meet the deportation machine’s local partners.
Health & Wellness
Opioid overdose deaths are up in communities of color, even as they decrease overall.
Courts & Law
The chain is accused of pressuring pharmacists to fill as many prescriptions as they could and rewarding them for doing it fast — ‘like McDonalds.’
Opinion
Some members of the notorious Sackler family have returned to blaming doctors for the opioid crisis. Are they even wrong?
Opinion
The opioid epidemic would not have been possible without the cooperation of the House of Medicine, from leading journals to the AMA.
Health & Wellness
Pharmaceutical companies gloated about how they intentionally tainted the medical literature, confusing a generation of doctors about the addiction potential of opioids.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.